Gijsberts Crystel M, Benson Lina, Dahlström Ulf, Sim David, Yeo Daniel P S, Ong Hean Yee, Jaufeerally Fazlur, Leong Gerard K T, Ling Lieng H, Richards A Mark, de Kleijn Dominique P V, Lund Lars H, Lam Carolyn S P
ICIN-Netherlands Heart Institute, Utrecht, The Netherlands Laboratory of Experimental Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Heart. 2016 Sep 15;102(18):1464-71. doi: 10.1136/heartjnl-2015-309212. Epub 2016 Jul 11.
QRS duration (QRSd) criteria for device therapy in heart failure (HF) were derived from predominantly white populations and ethnic differences are poorly understood.
We compared the association of QRSd with ejection fraction (EF) and outcomes between 839 Singaporean Asian and 11 221 Swedish white patients with HF having preserved EF (HFPEF)and HF having reduced EF (HFREF) were followed in prospective population-based HF studies.
Compared with whites, Asian patients with HF were younger (62 vs 74 years, p<0.001), had smaller body size (height 163 vs 171 cm, weight 70 vs 80 kg, both p<0.001) and had more severely impaired EF (EF was <30% in 47% of Asians vs 28% of whites). Overall, unadjusted QRSd was shorter in Asians than whites (101 vs 104 ms, p<0.001). Lower EF was associated with longer QRSd (p<0.001), with a steeper association among Asians than whites (pinteraction<0.001), independent of age, sex and clinical covariates (including body size). Excluding patients with left bundle branch block (LBBB) and adjusting for clinical covariates, QRSd was similar in Asians and whites with HFPEF, but longer in Asians compared with whites with HFREF (p=0.001). Longer QRSd was associated with increased risk of HF hospitalisation or death (absolute 2-year event rate for ≤120 ms was 40% and for >120 ms it was 52%; HR for 10 ms increase of QRSd was 1.04 (1.03 to 1.06), p<0.001), with no interaction by ethnicity.
We found ethnic differences in the association between EF and QRSd among patients with HF. QRS prolongation was similarly associated with increased risk, but the implications for ethnicity-specific QRSd cut-offs in clinical decision-making require further study.
心力衰竭(HF)器械治疗的QRS波时限(QRSd)标准主要源自白人人群,种族差异尚不清楚。
在基于人群的前瞻性HF研究中,我们比较了839名新加坡亚洲HF患者和11221名瑞典白人HF患者的QRSd与射血分数(EF)及预后的关系,这些患者包括射血分数保留的心力衰竭(HFpEF)和射血分数降低的心力衰竭(HFrEF)患者。
与白人相比,亚洲HF患者更年轻(62岁对74岁,p<0.001),体型更小(身高163cm对171cm,体重70kg对80kg,均p<0.001),且EF受损更严重(47%的亚洲人EF<30%,而白人中这一比例为28%)。总体而言,未调整的QRSd亚洲人比白人短(101ms对104ms,p<0.001)。较低的EF与较长的QRSd相关(p<0.001),亚洲人与白人相比这种相关性更强(p交互作用<0.001),且独立于年龄、性别和临床协变量(包括体型)。排除左束支传导阻滞(LBBB)患者并对临床协变量进行调整后,HFpEF的亚洲人和白人的QRSd相似,但HFrEF的亚洲人QRSd比白人更长(p=0.001)。较长的QRSd与HF住院或死亡风险增加相关(QRSd≤120ms的2年绝对事件发生率为40%,>120ms为52%;QRSd每增加10ms的风险比为1.04(1.03至1.06),p<0.001),且不存在种族交互作用。
我们发现HF患者中EF与QRSd之间的关联存在种族差异。QRS延长同样与风险增加相关,但在临床决策中针对特定种族的QRSd临界值的意义需要进一步研究。